The Sherwin-Williams Company filings document operating results, governance actions, and capital-structure matters for an Ohio paint and coatings issuer with common stock listed on the New York Stock Exchange under SHW. Recent Form 8-K reports furnish quarterly and annual financial results, including net sales, earnings measures, segment performance, guidance, and Valspar acquisition-related amortization.
Proxy and annual-meeting filings cover director elections, advisory executive-compensation votes, auditor ratification, shareholder voting results, and pay-versus-performance disclosures. Other 8-K filings record material definitive agreements, amendments to credit facilities, borrowing and letter-of-credit commitments, covenants, events of default, and related direct financial obligations.
Sherwin Williams Co. (SHW) reported that SVP - CHRO Marlena K. Boyce received a grant of 6,220 employee stock options on October 20, 2026, with an exercise price of $335.04 per share. The options are for common stock, expire October 19, 2036, and were granted under the 2025 Equity and Incentive Compensation Plan.
Sherwin-Williams (SHW) President, Glob. Architectural Justin T. Binns received a grant of 12,055 employee stock options on October 20, 2026. The options have an exercise price of $335.04 per share, expire October 19, 2036, and were granted under the 2025 Equity and Incentive Compensation Plan.
Sherwin-Williams Co. (SHW) director Thomas Williams acquired 104.12 deferred stock units on October 2, 2026, in an exempt transaction under the 2005 Director Deferred Fee Plan. The transaction-date weighted average share price of $324.14 was used to determine the number of units credited. The Deferred Fee Plan position after the acquisition was 1,369.35 deferred stock units, including units acquired through the plan’s dividend reinvestment feature. A separate line for previously reported direct holdings lists 1,100 restricted stock units and 1,271 common shares.
Sherwin Williams Co. (SHW) director Michael H. Thaman acquired 104.12 deferred stock units on October 2, 2026, under the 2005 Director Deferred Fee Plan. The $324.14 weighted average share price was used to determine the number of units credited. The units are economically equivalent to common shares and payable solely in stock, generally after his separation from service as a director. No Rule 10b5-1 plan is reported. His indirect deferred stock unit holdings afterward were 5,830.87 units. A separate previously reported direct holding line lists 1,100 restricted stock units and 7,011 common shares.
Sherwin-Williams director Robert James Gamgort acquired 104.12 deferred stock units on October 2, 2026, in an exempt transaction under the 2005 Director Deferred Fee Plan. The units are the economic equivalent of common shares and are payable solely in stock, generally following his separation from service as a director. His reported indirect deferred-unit balance after the acquisition was 691.12. A separate, previously reported direct holding comprised 1,075 securities: 902 restricted stock units and 173 common shares.
Sherwin-Williams (SHW) director Kerrii B. Anderson acquired 30.85 deferred stock units on October 2, 2026, under the 2005 Director Deferred Fee Plan. The $324.14 weighted-average share price was used to determine the number of units credited. The units are payable solely in stock, generally following her separation from service as a director; her reported deferred-unit balance afterward was 1,109.95. No Rule 10b5-1 plan is reported. A separate, previously reported holding entry lists 5,819 securities: 1,100 restricted stock units and 4,719 common shares.
The Sherwin-Williams Company (SHW) entered into a new $750 million U.S.-dollar-denominated senior unsecured term loan agreement, and SW Luxembourg entered into a €100 million term loan agreement.
The existing 364-day senior unsecured delayed draw term loan agreement was repaid and terminated on September 24, 2026, in connection with borrowing under the new agreements. The U.S. facility matures on September 23, 2027, and may be used to refinance the existing agreement and for general corporate purposes, including working capital. The euro loan to SW Luxembourg has the same maturity date and may be extended at its election by up to two additional six-month periods; Sherwin-Williams guarantees that loan. The U.S. agreement limits the consolidated leverage ratio to 3.75 to 1.00 as of the last day of any fiscal quarter. Following a Qualifying Acquisition, Sherwin-Williams may elect, subject to customary conditions, to temporarily increase the limit to 4.25 to 1.00 for four consecutive fiscal quarters.
SHERWIN WILLIAMS CO (SHW) executive Justin T. Binns, President, Glob. Architectural, reported multiple transactions in Sherwin-Williams common stock. On August 17, 2026, he exercised 13,500 stock options with a $90.04 exercise price, receiving an equal number of common shares, and on the same date sold 13,500 shares at a weighted average price of about $352.70 per share in multiple trades between $353.01 and $352.66.
On August 18, 2026, he made a bona fide gift of 813 shares to a charitable donor advised fund. Following these transactions, 6,009.63 shares of common stock are attributable to his participation in The Sherwin-Williams Company 401(k) Plan, reported as indirect ownership. The exercised options, granted in 2016, are now fully exhausted according to this report.
Justin T. Binns, an officer of Sherwin-Williams Co., reported a proposed sale of 13,500 common shares, with an aggregate market value of $4,761,442.55 and an approximate sale date of August 17, 2026. The shares were acquired from the issuer through a stock option exercise on August 17, 2026, with cash payment. Fidelity Brokerage Services LLC is named as broker.
Sherwin-Williams Company officer Karl J. Jorgenrud, President, Global Industrial, reported several equity transactions on 2026-08-07. He exercised 90 stock options at an exercise price of $127.98 per share, receiving 90 shares of common stock. On the same date, he sold 7,886 shares of Sherwin-Williams common stock at $368.30 per share in a sale transaction. Following the option exercise, he held 4,260 employee stock options directly, expiring 2027-10-17, and had 1,252.54 shares of common stock attributable to his participation in The Sherwin-Williams Company 401(k) Plan as of 2026-06-30. The transactions are not indicated as being made pursuant to a Rule 10b5-1 trading plan.